$2.5m To Be Invested Into Stomach & Oesophageal Cancer Research

Pancare Foundation welcomes the news that translational cancer research projects, focusing on oesophageal and stomach cancer, will be supported through the latest Victorian Cancer Agency funding round.

2.5m to be invested into stopmach and ...

Translational research is designed to fast-track the conversion of ground breaking cancer research findings into clinical practice and new treatments that deliver better care and outcomes for patients.

Over 3 years, approximately $2.5M will be invested into research focusing on stomach and oesophageal cancer.

The oesophageal cancer project focuses on the effectiveness of a new drug (APR-246). Pancare would like to congratulate, lead researcher Prof Wayne Phillips of Peter MacCallum Cancer Centre and joining him in the study is Pancare medical advisor, A/Prof Niall Tebbutt of Austin Health.

The second study, looks at a very early, dietician-led, nutrition intervention program, to improve body weight, body muscle and fat stores and quality of life of those newly diagnosed with stomach or oesophageal cancer. We congratulate Prof Terry Haines of Monash University.

According to the Australian Institute of Health and Welfare, approximately 2,230 Australians are diagnosed with stomach and oesophageal cancer every year in Australia.

You can read the full media release from the Victoria State Government here.

Further Reading – References & Resources